v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2025   991,488,000        
Beginning balance at Jan. 31, 2025 $ 3,318,917 $ 496 $ 4,409,131 $ (1,120,540) $ (9,593) $ 39,423
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   1,060,000        
Issuance of common stock upon exercise of options 2,355   2,355      
Issuance of common stock under RSU and PSU release (in shares)   9,608,000        
Issuance of common stock under RSU and PSU release 0 $ 6 (6)      
Issuance of common stock under employee stock purchase plan (in shares)   1,100,000        
Issuance of common stock under employee stock purchase plan 74,622   74,622      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   52,000        
Issuance of common stock for founders holdbacks related to acquisitions 6,136   6,136      
Issuance of common stock for payment of board of director fees 176   176      
Stock-based compensation expense, net of founder revest 524,290   524,290      
Capitalized stock-based compensation 28,431   28,431      
Net income (loss) (175,173)     (174,417)   (756)
Non-controlling interest (656)         (656)
Other comprehensive income (loss) 15,593       15,593  
Ending balance (in shares) at Jul. 31, 2025   1,003,308,000        
Ending balance at Jul. 31, 2025 3,794,691 $ 502 5,045,135 (1,294,957) 6,000 38,011
Beginning balance (in shares) at Apr. 30, 2025   996,297,000        
Beginning balance at Apr. 30, 2025 3,491,014 $ 498 4,669,328 (1,224,804) 5,855 40,137
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   763,000        
Issuance of common stock upon exercise of options 1,721   1,721      
Issuance of common stock under RSU and PSU release (in shares)   5,095,000        
Issuance of common stock under RSU and PSU release 0 $ 4 (4)      
Issuance of common stock under employee stock purchase plan (in shares)   1,100,000        
Issuance of common stock under employee stock purchase plan 74,622   74,622      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   52,000        
Issuance of common stock for founders holdbacks related to acquisitions 6,136   6,136      
Issuance of common stock for payment of board of director fees (in shares)   1,000        
Issuance of common stock for payment of board of director fees 88   88      
Stock-based compensation expense, net of founder revest 278,104   278,104      
Capitalized stock-based compensation 15,140   15,140      
Net income (loss) (70,123)     (70,153)   30
Non-controlling interest (2,156)         (2,156)
Other comprehensive income (loss) 145       145  
Ending balance (in shares) at Jul. 31, 2025   1,003,308,000        
Ending balance at Jul. 31, 2025 3,794,691 $ 502 5,045,135 (1,294,957) 6,000 38,011
Beginning balance (in shares) at Jan. 31, 2026   1,013,453,000        
Beginning balance at Jan. 31, 2026 $ 4,472,605 $ 507 5,694,169 (1,283,042) 16,756 44,215
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares) 636,000 636,000        
Issuance of common stock upon exercise of options $ 1,669   1,669      
Issuance of common stock under RSU and PSU release (in shares)   9,376,000        
Issuance of common stock under RSU and PSU release $ 0 $ 6 (6)      
Repurchases of common stock (in shares) (1,920,000) (1,920,000)        
Repurchases of common stock $ (175,622) $ (1) (175,621)      
Issuance of common stock under employee stock purchase plan (in shares)   1,035,000        
Issuance of common stock under employee stock purchase plan 86,624   86,624      
Issuance of common stock for restricted stock awards (in shares)   1,240,000        
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   23,000        
Issuance of common stock for founders holdbacks related to acquisitions 3,068   3,068      
Issuance of common stock for payment of board of director fees (in shares)   2,000        
Issuance of common stock for payment of board of director fees 208   208      
Stock-based compensation expense, net of founder revest 665,522   665,522      
Capitalized stock-based compensation 36,908   36,908      
Fair value of replacement equity awards attributable to pre-acquisition service 22,949   22,949      
Net income (loss) 51,272     33,080   18,192
Non-controlling interest (24,606)         (24,606)
Other comprehensive income (loss) (1,072)       (1,072)  
Ending balance (in shares) at Jul. 31, 2026   1,023,845,000        
Ending balance at Jul. 31, 2026 5,139,525 $ 512 6,335,490 (1,249,962) 15,684 37,801
Beginning balance (in shares) at Apr. 30, 2026   1,018,149,000        
Beginning balance at Apr. 30, 2026 4,675,332 $ 509 5,852,987 (1,255,268) 35,649 41,455
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   375,000        
Issuance of common stock upon exercise of options 986   986      
Issuance of common stock under RSU and PSU release (in shares)   4,276,000        
Issuance of common stock under RSU and PSU release $ 0 $ 3 (3)      
Repurchases of common stock (in shares) 0          
Repurchases of common stock $ 0          
Issuance of common stock under employee stock purchase plan (in shares)   1,035,000        
Issuance of common stock under employee stock purchase plan 86,624   86,624      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   9,000        
Issuance of common stock for founders holdbacks related to acquisitions 1,534   1,534      
Issuance of common stock for payment of board of director fees (in shares)   1,000        
Issuance of common stock for payment of board of director fees 105   105      
Stock-based compensation expense, net of founder revest 372,291   372,291      
Capitalized stock-based compensation 20,966   20,966      
Net income (loss) 5,306     5,306    
Non-controlling interest (3,654)         (3,654)
Other comprehensive income (loss) (19,965)       (19,965)  
Ending balance (in shares) at Jul. 31, 2026   1,023,845,000        
Ending balance at Jul. 31, 2026 $ 5,139,525 $ 512 $ 6,335,490 $ (1,249,962) $ 15,684 $ 37,801